Responses
Poster Presentations
Psoriatic arthritis
SAT0579 Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials (Future 1 and Future 2)
Compose a Response to This Article
Other responses
No responses have been published for this article.